-

HCA Healthcare to Sell North Georgia Hospital to AdventHealth

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the signing of a definitive agreement to sell Redmond Regional Medical Center, a 230 bed hospital in Rome, Georgia, to AdventHealth for approximately $635 million. The sale completes the company’s divestiture of hospitals in the surrounding areas of Atlanta.

HCA Healthcare colleagues at Redmond Regional Medical Center have served the community for 48 years, and the hospital has gained national recognition for quality care. For two years in a row, IBM Watson Health has recognized Redmond Regional as a Top 100 U.S. Hospital.

As a result of the sale of Redmond Regional Medical Center, a hospital that was not able to fully benefit from a broader HCA Healthcare network in the area, the company will no longer have a presence in northwest Georgia. The transaction provides strategic value to HCA Healthcare by increasing financial flexibility for investments in ongoing and future initiatives in core markets.

HCA Healthcare, which has a long history of caring for communities in Georgia, currently operates four other hospitals in the state. Additionally, HCA Healthcare recently expanded its network of care in southeast Georgia with the purchase of Meadows Regional Hospital in Vidalia, Georgia from Meadows Health Alliance.

Citi is serving as financial advisor to HCA Healthcare. The transaction is subject to customary regulatory approvals and expected to close in the third quarter of 2021.

About HCA Healthcare

Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 186 hospitals and approximately 2,000 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44 percent. HCA Healthcare is a learning health system that uses its more than 32 million annual patient encounters to advance science, improve patient care and save lives. Please click here to connect with HCA Healthcare on social media.

All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to
HCA Healthcare, Inc. and its affiliates.

Contacts

INVESTOR CONTACT:
Mark Kimbrough
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

HCA Healthcare

NYSE:HCA

Release Versions

Contacts

INVESTOR CONTACT:
Mark Kimbrough
615-344-2688

MEDIA CONTACT:
Harlow Sumerford
615-344-1851

More News From HCA Healthcare

HCA Healthcare Announces Dr. Michael Schlosser as Executive Vice President and Chief Clinical Officer; Names Charles Gressle President of New Ambulatory Operations Group

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare’s East Florida Division, has been appointed president of HCA Healthcare’s new Ambulatory Operations Group. Dr. Schlosser will succeed Dr. Michael Cuffe, who a...

HCA Healthcare Reports Second Quarter 2026 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2026. The Company's financial and operating results, as well as its updated guidance and key assumptions, are consistent with its July 14, 2026 second quarter preview. Key second quarter metrics (all percentage changes compare 2Q 2026 to 2Q 2025 unless otherwise noted): Revenues increased 8.7 percent to $20.230 billion Net income attributable...

HCA Healthcare, Inc. 2nd Quarter 2026 Earnings Conference Call

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2026 Earnings Call When: Friday, July 24, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If you are unable to listen during the live webcast, the call will be...
Back to Newsroom